title: Chimerism induction in vascularized bone marrow transplants augmented with bone marrow cells.
abstract: Composite tissue allografts (CTAs) are currently accepted in the clinic; however, long-term immunosuppression is still needed for allograft survival. The presence of donor-specific chimerism may induce tolerance. Thirty-six vascularized bone marrow transplantation (VBMT) allotransplantation were performed across MHC barrier under short-term protocol of 7-day alphabeta-TCRmAb and Cyclosporin A therapy to determine the efficacy of VBMT alone and VBMT augmented with donor bone marrow transplantation (BMT) in chimerism induction. Flow cytometry analysis revealed that VBMT supported with donor BMT directly into the bone resulted in chimerism augmentation and maintenance compared to VBMT. In vivo and in vitro tolerance testing showed prolonged survival of donor skin graft up to 35 days and moderate reactivity in MLR assay that suggests only tolerance induction. Transplantation of vascularized bone without chronic immunosuppression provides a substantial source of bone marrow cells, leading to the development of stable donor-specific chimerism.
authors.affiliation: Department of Plastic Surgery, The Cleveland Clinic, Cleveland, OH 44195, USA.
authors.forename: Emrah
authors.initials: E
authors.lastname: Arslan
authors.forename: Aleksandra
authors.initials: A
authors.lastname: Klimczak
authors.forename: Maria
authors.initials: M
authors.lastname: Siemionow
mesh_terms: D000818:Animals; D016026:Bone Marrow Transplantation / Q000276:immunology*; D046528:Chimerism; D005269:Femur / Q000637:transplantation; D005434:Flow Cytometry; D007959:Lymphocyte Culture Test, Mixed; D051381:Rats; D017207:Rats, Sprague-Dawley; D023001:Transplantation Tolerance / Q000235:genetics; D014184:Transplantation, Homologous; D014654:Vascular Patency